News | November 12, 2014

Mevion Medical Systems Delivers Proton Accelerator to UF Health Cancer Center

Accelerator is core component of high-tech proton beam therapy system to treat cancer in adults and children

Mevion Medical Systems, proton beam therapy, proton accelarator, Mevian S250

The Mevion S250 accelerator, being lifted by a crane as it is delivered to the UF Health Cancer Center. Photo: Orlando Health

Nov. 12, 2014 — Mevion Medical Systems will deliver  its Mevion S250 proton therapy superconducting synchrocyclotron accelerator to the University of Florida Health Cancer Center at Orlando Health. The accelerator will treat cancer in adults and children.

Proton therapy precisely delivers radiation doses to tumors while sparing much of the surrounding healthy tissue, thus making it ideal for treating pediatric patients, as well as adult cancers in sensitive locations such as near the heart or brain. As Central Florida’s most advanced cancer center, the UF Health Cancer Center – Orlando Health is the first hospital in the region to install a proton therapy system. Installation of the accelerator will take just a few days, and construction of the proton center is expected to be completed next year.

The MEVION S250 is a proton therapy platform. It requires less space and has lower capital and operational costs than traditional systems. Also, it is a flexible solution; any health care organization can install one single-room Mevion proton thereapy system, or as many as they need to treat their patient population.

Like the rest of the Mevion S250 system, the accelerator itself is highly advanced, compact, patented technology. Due to its small size, it is the only proton beam cyclotron accelerator that can easily be delivered and installed. Consequently, its journey from Mevion’s Boston area headquarters to Orlando was a simple drive down I-95. Designed and manufactured in the United States, the accelerator delivered to Orlando is one of only six in the entire world.

The first Mevion S250 was installed last December at the Kling Center for Proton Therapy at Barnes-Jewish Hospital at Washington University in St. Louis, Mo., and is already treating more than 20 pediatric and adult cancer patients per day. The system is running with 97% uptime.

Five additional Mevion S250s are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City, Okla.; Ackerman Cancer Center in Jacksonville, Fla.; University Hospitals Seidman Cancer Center in Cleveland, Ohio; and MedStar Georgetown University Hospital in Washington, D.C.

For more information: www.mevion.com

Related Content

Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Overlay Init